Dr. Sznol is a professor of medicine and leader of the melanoma/RCC disease-associated research team at Yale University. His major interests include cancer immunotherapy, drug development for cancer and treatment of patients with melanoma and renal cell carcinoma.
At Yale, Dr. Sznol he has served as chair of the protocol review committee and the quality assurance and compliance committee, and as associate chief of medical oncology. He also was co-director of the Yale SPORE in Skin Cancer. Prior to his time at Yale, he was vice president of clinical development for Vion Pharmaceuticals, and was a senior investigator in the Investigational Drug Branch of the Cancer Therapy Evaluation Program and head of the Biologics Evaluation Program at the National Cancer Institute.
Dr. Sznol received a bachelor’s degree in biochemistry from Rice University and his medical degree from Baylor College of Medicine. He completed a fellowship in medical oncology at Mount Sinai College of Medicine in New York.